|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 2/26/03 Martek Biosciences Corp 8-K:7,9 2/25/03 2:16K Bowne - DC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 14K 2: EX-99.1 Press Release HTML 8K
| Page | (sequential) | | | (alphabetic) | Top | |
|---|---|---|---|---|---|
| 1 | 1st Page - Filing Submission | ||||
| " | Table of Contents | ||||
| " | Item 7. Financial Statements and Exhibits | ||||
| " | Item 9. Regulation FD Disclosure | ||||
| " | Signatures | ||||
| e8vk |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2003
Martek Biosciences Corporation
| Delaware | 000-22354 | 52-1399362 | ||
|
|
||||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 6480 Dobbin Road Columbia, Maryland | 21045 | |||
|
|
||||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code: (410) 740-0081
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| Press Release | ||||||||
MARTEK BIOSCIENCES CORPORATION
Item 7. Financial Statements and Exhibits.
99.1 Press Release, issued February 25, 2003.
Item 9. Regulation FD Disclosure.
On February 25, 2003, Martek Biosciences Corporation issued the press release attached hereto as Exhibit 99.1 concerning the closing of a one-year $10 million secured working capital line of credit facility with Allfirst Bank of Baltimore, Md. The press release is incorporated herein by this reference.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MARTEK BIOSCIENCES CORPORATION | ||||
| Date: February 25, 2003 | By: | /s/ Peter L. Buzy | ||
| Peter L. Buzy | ||||
| Chief Financial Officer | ||||
-3-
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/26/03 | None on these Dates | ||
| For Period End: | 2/25/03 | |||
| List all Filings | ||||